Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis

Arthritis Research and Therapy

Volumn 8, Issue 4, 2006, Pages

  Morgan, Ann W ^a   Robinson, Jim I ^a   Barrett, Jennifer H ^a   Martin, Javier ^b   Walker, Amy ^a   Babbage, Sarah J ^a   Ollier, William E R ^c   Gonzalez Gay, Miguel A ^d   Isaacs, John D ^a,e  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d HOSPITAL XERAL CALDE   (Spain)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FCGR2A PROTEIN, HUMAN; FCGR2B PROTEIN, HUMAN; FCGR3A PROTEIN, HUMAN; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; LEUKOCYTE ANTIGEN;

ALLELE; BLOOD; CHROMOSOME MAP; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GIANT CELL ARTERITIS; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN;

ALLELES; ANTIGENS, CD; CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GIANT CELL ARTERITIS; GPI-LINKED PROTEINS; HAPLOTYPES; HETEROZYGOTE; HLA-DR ANTIGENS; HLA-DRB1 CHAINS; HOMOZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC; RECEPTORS, IGG;

EID: 34247551145     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1996     Document Type: Article

References (40)

1. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Dlorca J: Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 2005, 84:269-276.
2. Nesher G, Sonnenblick M, Friedlander Y: Analysis of steroid related complications and mortality in temporal arteritis: A 15- year survey of 43 patients. J Rheumatol 1994, 21:1283-1286.
3. Ma-Krupa W, Jeon M-S, Spoerl S, Tedder TF, Goronzy JJ, Weyand CM: Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004, 199 173-183.
4. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE: Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003, 33 38-48.
5. Salvarani C, Boiardi L, Mantovani V, Ranzi A, Cantini F, Olivieri I, Bragliani M, Collina E, Macchioni P: HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: Correlation with disease severity. Ann Rheum Dis 1999, 58:303-308.
6. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH, Branas F, Dababneh A, Gonzalez-Louzao C, Rodriguez-Gil E, Rodriguez- Ledo P, Ollier WE: Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000, 79:283-292.
7. Rauzy O, Fort M, Nourhashemi F, Alric L, Juchet H, Ecoiffier M, Abbal M, Adoue D: Relation between HLA DRB1 alleles and corticosteroid resistance in giant cell arteritis. Ann Rheum Dis 1998, 57 380-382.
8. Mattey DL, Hajeer AH, Dababneh A, Thomson W, Gonzalez-Gay MA, Garcia-Porrua C, Ollier WE: Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum 2000, 43 1749-1755.
9. Amoli MM, Gonzalez-Gay MA, Zeggini E, Salway F, Garcia-Porrua C, Ollier WE: Epistatic interactions between HLA-DRB1 and interleukin 4, but not interferon-gamma, increase susceptibility to giant cell arteritis J Rheumatol 2004, 31:2413-2417.
10. Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D, Farnetti E, Brini M, Portioli I: Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. J Rheumatol 2000, 27:1215-1221.
11. Boiardi L, Casali B, Nicoli D, Farnetti E, Chen Q, Macchioni P, Catanoso MG, Pulsatelli L, Meliconi R, Salvarani C: Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol 2003, 30:2160-2164.
12. Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martin J, Gonzalez-Gay MA: A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 2005, 32:1737-1741.
13. Salvarani C, Casali B, Nicoli D, Farnetti E, Macchioni P, Catanoso MG, Chen Q, Bajocchi G, Boiardi L: Endothelial nitric oxide synthase gene polymorphisms in giant cell arteritis. Arthritis Rheum 2003, 48:3219-3223.
14. Amoli MM, Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA: Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis. J Rheumatol 2003, 30 2019-2022.
15. Jacobsen S, Baslund B, Madsen HO, Tvede N, Svejgaard A, Garred P: Mannose-binding lectin variant alleles and HLA-DR4 alleles are associated with giant cell arteritis. J Rheumatol 2002, 29 2148-2153.
16. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG: The incidence of giant cell arteritis in Olmsted County, Minnesota - apparent fluctuations in a cyclic pattern. Ann Intern Med 1995, 123 192-194.
17. Seo P, Stone JH: Large-vessel vasculitis. Arthritis Rheum 2004, 51:128-139.
18. Hoffman G: Large-vessel vasculitis. Unresolved issues. Arthritis Rheum 2003, 48:2406-2414.
19. Schmits R, Kubuschok B, Schuster S, Preuss K-D, Pfreudschuh M: Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica. Clin Exp Immunol 2002, 127:379-385.
20. Duhaut P, Berruyer M, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, Dechavanne M, Ninet J, Pasquier J, for the Groupe de Recherche sur l'Artérite à Cellules Géantes: Anticardiolipin antibodies and giant cell arteritis. Arthritis Rheum 1998, 41:701-709.
21. Manna R, Latteri M, Cristiano C, Todaro L, Scuderi F, Gasbarrini G: Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: A study of 40 cases. Br J Rheumatol 1998, 37 208-210.
22. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y: Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implications. Arthritis Rheum 2001, 44:1484-1494.
23. Salmon JE, Pricop L: Human recepKors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001, 44:739-750.
24. Ravetch JV, Bolland S: IgG Fc Receptors. Annu Rev Immunol 2001, 19:275-290.
25. Takai T: Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002, 2:580-592.
26. Regnault A, Lankar D, Lacabanne V, Rodriguez A, Théry C, Rescigno M, Saito T, Verbeek S, Bonnerot C, Ricciardi-Castagnoli P, et al.: Fcg receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class Irestricted antigen presentation after immune complex internalisation. J Exp Med 1999, 189 371-380.
27. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE: The spectrum of polymyalgia rheumatica in northwestern Spain: Incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol 1999, 26:1326-1332.
28. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworth SM, Fauci AS, Leavitt RY, Lie JT, et al.: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122-1128.
29. Warmerdam PA, Nabben NMJ, van de Graaf SA, van de Winkel JG, Capel PJ: The human low affinity immunoglobulin G Fc receptor IIC gene is a result of an unequal cross-over event. J Biol Chem 1993, 268 7346-7349.
30. Morgan AW, Keyte VH, Babbage SJ, Robinson JI, Ponchel F, Barrett JH, Bhakta BB, Bingham SJ, Buch MH, Conaghan PG, et al.: FcgRIIIA-158V and rheumatoid arthritis. A confirmation study. Rheumatology (Oxford) 2003, 42:528-533.
31. Morgan AW, Barrett JH, Griffiths B, Subramanian D, Robinson JI, Keyte VH, Ali M, Jones EA, Old RW, Ponchel F, et al.: Analysis of Fcg receptor haplotypes in rheumatoid arthritis. FCGR3A remains a major susceptibility gene at this locus with an additional contribution from FCGR3B. Arthritis Res Therapy 2005, 8:R5.
32. Su K, Wu J, Edberg JC, McKenzie SE, Kimberly RP: Genomic organization of classical human low-affinity Fcgamma receptor genes. Genes Immun 2002, 3(Suppl 1):S51-S56.
33. Zhao JH, Curtis D, Sham PC: Model-free analysis and permutation tests for allelic associations. Hum Hered 2000, 50:133-139.
34. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG: Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002, 53:79-91.
35. Cordell HJ, Clayton DG: A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: Application to HLA in Type 1 diabetes. Am J Hum Genet 2002, 70:124-141.
36. Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, Schork NJ: Genetic analysis of case/control data using estimated haplotype frequencies: Application to APOE locus variation and Alzheimer's disease Genome Res 2001, 11:143-151.
37. Fijen CAP, Bredius RGM, Kuijper EJ: Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med 1993, 119:636.
38. Musser JM, Kroll JS, Granoff DM, Moxon ER, Brodeur BR, Campos J, Dabernat H, Frederikson W, Hamel J, Hammond G, et al.: Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis 1990, 12:75-111.
39. Domingo P, Muñiz-Diaz E, Baraldès MA, Arilla M, Barquet N, Pericas R, Juárez C, Madoz P, Vázquez G: Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease. Am J Med 2002, 112:19-25.
40. Dijstelbloem HM, Scheepers RHM, Oost WW, Stegeman CA, van der Pol WL, Sluiter WJ, Kallenberg CGM, van de Winkel JGJ, Tervaert JWC: Fcg receptor polymorphisms in Wegener's granulomatosis: Risk factors for disease relapse. Arthritis Rheum 1999, 42:1823-1827.